Cipher Pharmaceuticals (CPH) Competitors

Cronos Group (TSE:CRON) and Cipher Pharmaceuticals (TSE:CPH) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership.

Is CRON or CPH more profitable?

Cipher Pharmaceuticals has a net margin of 59.92% compared to Cronos Group's net margin of -42.65%. Cipher Pharmaceuticals' return on equity of 17.93% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-42.65%	-4.40%	-3.73%
Cipher Pharmaceuticals	59.92%	17.93%	7.90%

Which has preferable earnings and valuation, CRON or CPH?

Cipher Pharmaceuticals has lower revenue, but higher earnings than Cronos Group. Cronos Group is trading at a lower price-to-earnings ratio than Cipher Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	C$76.86M	9.45	-C$32.78M	-C$0.18	-15.30
Cipher Pharmaceuticals	C$19.03M	11.63	C$11.41M	C$0.91	13.62

Which has more risk and volatility, CRON or CPH?

Cronos Group has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500. Comparatively, Cipher Pharmaceuticals has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500.

Does the media refer more to CRON or CPH?

In the previous week, Cipher Pharmaceuticals had 1 more articles in the media than Cronos Group. MarketBeat recorded 1 mentions for Cipher Pharmaceuticals and 0 mentions for Cronos Group. Cipher Pharmaceuticals' average media sentiment score of 0.75 beat Cronos Group's score of 0.00 indicating that Cipher Pharmaceuticals is being referred to more favorably in the news media.

Company	Overall Sentiment
Cronos Group	Neutral
Cipher Pharmaceuticals	Positive

Do institutionals & insiders hold more shares of CRON or CPH?

16.0% of Cronos Group shares are held by institutional investors. Comparatively, 1.4% of Cipher Pharmaceuticals shares are held by institutional investors. 46.4% of Cronos Group shares are held by insiders. Comparatively, 42.0% of Cipher Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Do analysts prefer CRON or CPH?

Cipher Pharmaceuticals has a consensus target price of C$14.75, suggesting a potential upside of 19.63%. Given Cipher Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe Cipher Pharmaceuticals is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Cipher Pharmaceuticals	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75

Summary

Cipher Pharmaceuticals beats Cronos Group on 14 of the 17 factors compared between the two stocks.